Exane Derivatives’s Genesis Energy GEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-39
Closed -$908 680
2019
Q1
$908 Sell
39
-3
-7% -$65 ﹤0.01% 504
2018
Q4
$776 Hold
42
﹤0.01% 581
2018
Q3
$1.02K Sell
42
-4
-9% -$94 ﹤0.01% 538
2018
Q2
$1.01K Buy
46
+2
+5% +$43 ﹤0.01% 526
2018
Q1
$834 Sell
44
-1
-2% -$22 ﹤0.01% 484
2017
Q4
$1K Buy
45
+8
+22% +$185 ﹤0.01% 486
2017
Q3
$975 Hold
37
﹤0.01% 457
2017
Q2
$1.17K Buy
37
+1
+3% +$31 ﹤0.01% 466
2017
Q1
$1.17K Sell
36
-1
-3% -$35 ﹤0.01% 409
2016
Q4
$1.33K Buy
37
+2
+6% +$70 ﹤0.01% 467
2016
Q3
$1.33K Sell
35
-5
-13% -$183 ﹤0.01% 471
2016
Q2
$1.53K Sell
40
-3
-7% -$105 ﹤0.01% 411
2016
Q1
$1.37K Hold
43
﹤0.01% 468
2015
Q4
$1.58K Hold
43
﹤0.01% 385
2015
Q3
$1.65K Hold
43
﹤0.01% 403
2015
Q2
$1.89K Hold
43
﹤0.01% 418
2015
Q1
$2.02K Sell
43
-362
-89% -$16.1K ﹤0.01% 421
2014
Q4
$17.2K Buy
+405
New +$18.6K ﹤0.01% 393

Other funds holding GEL

Exane Derivatives's GEL Position: Q2 2019 in Review

Exane Derivatives sold out of Genesis Energy (GEL) in Q2 2019, closing a stake of 39 shares — an estimated $908 sold.

Exane Derivatives first reported a position in GEL in Q4 2014 and held it in 18 quarters. The position peaked at $17.2K in Q4 2014. 141 funds tracked by Wall St. Rank hold GEL as of Q2 2019.

  • Exane Derivatives reported no remaining Genesis Energy position as of Q2 2019 after selling out during the quarter.
  • Exane Derivatives sold 39 Genesis Energy shares in Q2 2019, an estimated $908.
  • Exane Derivatives first reported a position in Genesis Energy in Q4 2014 and held it in 18 quarters.
  • Exane Derivatives's Genesis Energy position peaked at $17.2K in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Genesis Energy as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.